Transcellular Targeting of Fiber- and Hexon-Modified Adenovirus Vectors across the Brain Microvascular Endothelial Cells In Vitro

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Laakkonen, Johanna P ^a   Engler, Tatjana ^a   Romero, Ignacio A ^b,e   Weksler, Babette ^b,f   Couraud, Pierre Olivier ^b,c,d   Kreppel, Florian ^a   Kochanek, Stefan ^a  

^a UNIVERSITY OF ULM   (Germany)

^b INSTITUT COCHIN   (France)

^c CNRS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e OPEN UNIVERSITY   (United Kingdom)

^f Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CYSTEINE; MALEIMIDE; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROVASCULAR ENDOTHELIAL CELL; NUCLEOTIDE SEQUENCE; POLARIZATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCYTOSIS; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID;

ADENOVIRIDAE; BLOOD-BRAIN BARRIER; BRAIN; CELL LINE; CELL LINE, TUMOR; ENDOTHELIAL CELLS; GENETIC VECTORS; HUMANS; TRANSDUCTION, GENETIC; TRANSFERRIN;

ADENOVIRIDAE; MIRIDAE;

EID: 84866940778     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045977     Document Type: Article

References (40)

1. Lichota J, Skjorringe T, Thomsen LB, Moos T, (2010) Macromolecular drug transport into the brain using targeted therapy. J Neurochem 113: 1-13.
2. Tuma PL, Hubbard AL, (2003) Transcytosis: crossing cellular barriers. Physiol Rev 83: 871-932.
3. Cecchelli R, Berezowski V, Lundquist S, Culot M, Renftel M, et al. (2007) Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 6: 650-661.
4. Jones AR, Shusta EV, (2007) Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 24: 1759-1771.
5. Herve F, Ghinea N, Scherrmann JM, (2008) CNS delivery via adsorptive transcytosis. Aaps J 10: 455-472.
6. Georgieva JV, Kalicharan D, Couraud PO, Romero IA, Weksler B, et al. (2010) Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro. Mol Ther 19: 318-325.
7. Glasgow JN, Everts M, Curiel DT, (2006) Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther 13: 830-844.
8. Thomas CE, Ehrhardt A, Kay MA, (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4: 346-358.
9. Manfredsson FP, Mandel RJ, (2010) Development of gene therapy for neurological disorders. Discovery Medicine 9: 204-211.
10. Barcia C, Jimenez-Dalmaroni M, Kroeger KM, Puntel M, Rapaport AJ, et al. (2007) One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications. Mol Ther 15: 2154-2163.
11. Smith-Arica JR, Morelli AE, Larregina AT, Smith J, Lowenstein PR, et al. (2000) Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression. Mol Ther 2: 579-587.
12. Miyoshi G, Fishell G, (2006) Directing neuron-specific transgene expression in the mouse CNS. Curr Opin Neurobiol 16: 577-584.
13. Thomas CE, Edwards P, Wickham TJ, Castro MG, Lowenstein PR, (2002) Adenovirus binding to the coxsackievirus and adenovirus receptor or integrins is not required to elicit brain inflammation but is necessary to transduce specific neural cell types. J Virol 76: 3452-3460.
14. Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, et al. (1993) Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 3: 224-228.
15. Lindemann D, Schnittler H, (2009) Genetic manipulation of endothelial cells by viral vectors. Thromb Haemost 102: 1135-1143.
16. Xia H, Anderson B, Mao Q, Davidson BL, (2000) Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium. J Virol 74: 11359-11366.
17. Tang Y, Han T, Everts M, Zhu ZB, Gillespie GY, et al. (2007) Directing adenovirus across the blood-brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model. Gene Ther 14: 523-532.
18. Corjon S, Wortmann A, Engler T, van Rooijen N, Kochanek S, et al. (2008) Targeting of adenovirus vectors to the LRP receptor family with the high-affinity ligand RAP via combined genetic and chemical modification of the pIX capsomere. Mol Ther 16: 1813-1824.
19. Kreppel F, Gackowski J, Schmidt E, Kochanek S, (2005) Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors. Mol Ther 12: 107-117.
20. Prill JM, Espenlaub S, Samen U, Engler T, Schmidt E, et al. (2010) Modifications of adenovirus hexon allow for either hepatocyte detargeting or targeting with potential evasion from Kupffer cells. Mol Ther 19: 83-92.
21. Poller B, Gutmann H, Krahenbuhl S, Weksler B, Romero I, et al. (2008) The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. J Neurochem 107: 1358-1368.
22. Cudkowicz A, Klausner RD, Bridges KR, (1984) Regulation of the transferrin receptor in K562 erythroleukemia cells. Prog Clin Biol Res 165: 509-519.
23. Goldsmith ME, Kitazono M, Fok P, Aikou T, Bates S, et al. (2003) The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells. Clin Cancer Res 9: 5394-5401.
24. Espenlaub S, Corjon S, Engler T, Fella C, Ogris M, et al. (2010) Capsomer-specific fluorescent labeling of adenoviral vector particles allows for detailed analysis of intracellular particle trafficking and the performance of bioresponsive bonds for vector capsid modifications. Hum Gene Ther 21: 1155-1167.
25. Campos SK, Barry MA, (2006) Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting. Virology 349: 453-462.
26. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. Faseb J 19: 1872-1874.
27. Franke H, Galla H, Beuckmann CT, (2000) Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro. Brain Res Brain Res Protoc 5: 248-256.
28. Franke H, Galla HJ, Beuckmann CT, (1999) An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res 818: 65-71.
29. Nitz T, Eisenblatter T, Psathaki K, Galla HJ, (2003) Serum-derived factors weaken the barrier properties of cultured porcine brain capillary endothelial cells in vitro. Brain Res 981: 30-40.
30. Moos T, Rosengren Nielsen T, Skjorringe T, Morgan EH, (2007) Iron trafficking inside the brain. J Neurochem 103: 1730-1740.
31. Pardridge WM, (1998) CNS drug design based on principles of blood-brain barrier transport. Journal Neurochem 70: 1781-1792.
32. Pardridge WM, (2002) Drug and gene targeting to the brain with molecular Trojan horses. Nat Rev Drug Discov 1: 131-139.
33. Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, et al. (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27: 59-65.
34. Batista L, Miller F, Clave C, Arfi A, Douillard-Guilloux G, et al. (2010) Induced secretion of beta-hexosaminidase by human brain endothelial cells: a novel approach in Sandhoff disease? Neurobiol Dis 37: 656-660.
35. Di Pasquale G, Chiorini JA, (2006) AAV transcytosis through barrier epithelia and endothelium. Mol Ther 13: 506-516.
36. Hocini H, Becquart P, Bouhlal H, Chomont N, Ancuta P, et al. (2001) Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells. J Virol 75: 5370-5374.
37. Pulzova L, Bhide MR, Andrej K, (2009) Pathogen translocation across the blood-brain barrier. FEMS Immunol Med Microbiol 57: 203-213.
38. Dehouck MP, Jolliet-Riant P, Bree F, Fruchart JC, Cecchelli R, et al. (1992) Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models. J Neurochem 58: 1790-1797.
39. Schiedner G, Hertel S, Kochanek S, (2000) Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production. Hum Gene Ther 11: 2105-2116.
40. Abramoff MD, Magelhaes PJ, Ram SJ, (2004) Image processing with ImageJ. Biophotonics Int. 11: 36.